Metallic nanoparticles have been utilized as analytical tools to detect a wide range of organic analytes. In most reports, gold (Au)-based nanosensors have been modified with ligands to introduce selectivity towards a specific target molecule.
Introduction
Nanosized objects of noble metals, i.e., Au, Ag, Pd, etc., have received enormous interest as their physicochemical properties differs significantly from larger objects of these elements. In particular, surface plasmon resonance (SPR) has been investigated and used in a number of biomedical applications, including diagnostic sensing [1] [2] [3] [4] [5] [6] , bio-imaging [7] [8] [9] [10] and therapeutic cancer therapy [11] [12] [13] . Development of cost-effective, readily available and reliable diagnostic biosensor technologies is especially important for the healthcare sector as early-stage detection of diseases offers both cost savings and dramatically improved clinical outcomes. To be an effective tool in such early stage diagnostics, biosensors must be capable of detecting very low concentrations of analyte, while also being highly selective in their response.
Therefore, development of biosensors with improved performance depends on designs that are highly selective for interactions with the target analyte and that present a large number of detection sites and/or present a strong reporter signal upon a detection event. Nano-dimensional objects have been heavily investigated to this end as they present a huge surface area for analyte binding and as binding events commonly can be detected by readily available UV-visible or fluorescent spectroscopy.
Among the nano-dimensional objects used to construct biosensors, gold nanoparticles (AuNPs) have likely received the most attention. They present unique optoelectronic behavior, high surface-to-volume ratio and a chemistry that allows for modification with functional ligands for sensitive and selective responses to a target analyte. Such responses include changes in plasmonic resonance absorption, conductivity or emission spectrum in response to changes in the surrounding environment [14] [15] [16] [17] [18] . Despite their attractive properties, implementation of metal NPs (including AuNPs) in applications has been limited by that they are prone to 4 aggregation that weakens or eliminates their desirable properties. To prepare metal nanoparticles for realistic applications there has been much work on new synthetic strategies and surface modifications [19] [20] [21] [22] . While the colloidal stability of AuNPs is critical to maintain their surface plasmon properties, it is equally important for biosensing applications that the biorecognition capability and response to the analyte is maintained [23] . Unfortunately, stabilizing molecules such as surfactants or other type of organic molecules on the AuNP surface often affect the SPR and may decrease the detection sensitivity.
There are, however, other routes than core-shell designs that result in excellent stability and biosensing performance of AuNPs. In a recent investigation we adsorbed bare-surface Au-nanorods (AuNR) onto positively charged nanocarriers of self-assembled amphiphilic carboxymethyl-hexanoyl chitosan (CHC) and investigated the system for detection of the protein human serum albumin (HSA) using conventional UV-visible spectroscopy [24] . The negatively charged AuNRs were rapidly adsorbed on the positively charged surface of the CHC nanocarriers and were thus stabilized as individual rods, forming a stable CHC-AuNR nanosuspension (termed -in the forthcoming discussion). Importantly and interestingly, by manipulating the pH the electrostatic interactions between the CHC nanocarriers, HSA, and deposited Au-nanorods could be tuned for excellent sensitivity and selectivity towards the analyte, without the use of any targeting ligands.
Although promising, a number of physiological challenges remain before this technology can be put to use and design parameters will need to be investigated and optimized for individual analytes and physiological environments.
In this work the CHC-AuNR nanoprobe was evaluated for detection of HSA in simulated urine (SU) while simultaneously investigating how the performance of the 5 system correlated with AuNR/CHC nanocarrier ratio and how the HSA adsorption kinetics depended on protein concentration. The selected model system is of relevance as the SU presents a moderately challenging environment that could interfere with the performance of the CHC-AuNR nanoprobe system and as the concentration of HSA in urine can be used as a marker for kidney function.
Methods

Materials
Gold nanorods with an aspect ratio of 5.2 were purchased from Nanorods, LLC, United States. Buffer solution (pH 5) was purchased from Alfa Aesar.
Carboxymethyl-hexanoyl chitosan (CHC) was purchased from Advanced Delivery
Technology Co, Taiwan. Ethanol (99.8%), creatine, Na 3 PO 4 , urea and albumin from human serum (HSA) were purchased from Sigma Aldrich and used as received. NaCl and KCl were purchased from J.T. Baker. All the solutions were prepared with ultrapure deionized water (DI water).
Preparation of simulated urine solution
To prepare SU 1.21 g of urea was added to 50 ml of DI water. Subsequently, 0.5 g NaCl, 0.3 g KCl, 0.32 g Na 3 PO 4 and 0.133 g of creatine were added to the solution.
Finally, different amounts of HSA were dissolved to achieve desired concentrations.
Preparation of CHC-AuNR nanoprobe solutions
CHC-AuNR nanoprobe solutions with different CHC to AuNR ratios were prepared by mixing 0.6, 0.45 or 0.3 ml AuNR solution (2·10 11 AuNR/ml) with DI water to a final volume of 1 ml. Subsequently, the samples were centrifuged at 15000 6 rpm for 15 minutes before addition of 0.1 mL of 1 wt% CHC solution and mixing.
Thereafter, 0.9 mL of ethanol was mixed with the dispersion to remove the CTAB from the AuNRs surfaces. Finally, the samples were centrifuged at 15000 rpm for 30 minutes, the supernatant containing ethanol and CTAB was decanted and the gel-like CHC-AuNR-NPs were re-dispersed into 1 ml of DI water. The different volumes of added AuNR dispersion resulted in different AuNR/CHC nanocarrier ratios that were estimated as previously reported [24] to 4, 3, and 2, for added AuNR dispersion volumes of 0.6, 0.45 and 0.3 ml, respectively. Before use in analyte detection 0.5 ml of the CHC-AuNR dispersion was mixed with 0.5 ml of pH 5 buffer solution for pH control, effectively forming the completed CHC-AuNR nanoprobe solution.
Analyses
-wise to 1 ml of the CHC-AuNR nanoprobe solution, followed by 15 minutes of incubation. Subsequently, absorption spectra were obtained using a UV-visible spectrophotometer (Thermo Scientific Evolution 3000, USA) and a quartz cuvette that had been cleaned by soaking in aqua regia and washed with DI water and ethanol. From the acquired spectra the peak shift was recorded for different HSA concentrations. Every test condition was measured three times on different samples and results are reported as averages with standard deviation, where applicable.
TEM and EDS mapping was performed using a JEOL JEM-2800F operated at 200 kV.
3. Results and discussion 3.1. Performance in simulated urine 7 It is known from the literature that both the absorbance maximum [25] and spectral shift in response to surrounding refractive index [26, 27] increases with the aspect ratio of an AuNR. In sensing applications, the increase in spectral shift with increasing aspect ratio is used for improved resolution and lower detection limit (LDL) when determining the analyte concentration. In this work, AuNRs with an average aspect ratio of 5.2 were utilized. See Table 1 for size characteristics and Fig. 1 for TEM image. shown for the CHC-AuNR nanoprobe in DI water that the adsorption of HSA and lysozyme on the Au-NRs was highly selective and effective close to the isoelectric point (IEP), pH = 5 and pH = 9 for HSA and lysozyme, respectively [24] . This behavior was explained by pH dependent electrostatic interactions that caused the analytes to preferentially adsorb on the AuNR-surfaces close to the IEP. The implications are that the nanoprobe system can be tuned towards selective detection of analytes through optimization of solution pH, i.e., the selectivity is not dependent on any specific ligands.
In this work the CHC-AuNR nanoprobe was evaluated and optimized for detection of HSA in SU. As a first step the absorption spectrum of the CHC-AuNR nanoprobe was recorded in DI water and SU and was compared with that of AuNRs.
As shown in Fig. 2a the CHC-AuNR nanoprobe presented a peak value that was red-shifted about 5 nm compared to pure AuNRs. However, there was little difference in peak values (about 0.1 nm) between DI water and SU at pH = 5. The similar peak values suggested that there was little-to-no interference from the compounds in the SU (i.e., creatine and urea) for the CHC-AuNR nanoprobe configuration used in the subsequent analyses (prepared with pH 5 buffer). The difference in absorbance may be due to slight differences in concentration or physicochemical factors, such as aggregation. However, since the peak shift is the critical parameter for the sensing, no further attention was given to the slight difference in absorbance. The peak shift in response to HSA concentration was also investigated in SU or DI water for the 9 CHC-AuNR system with an AuNR/CHC ratio of 4. As seen in Fig. 2b 
The effect of AuNR/CHC ratio on lower detection limit
The LDL of SPR-based sensors for various applications has been a subject of interests over the last decade [28] [29] [30] [31] . Here the impact of the ratio between AuNRs and CHC on HSA detection was investigated for the CHC-AuNR nanoprobe system.
The investigated AuNR/CHC ratios were 4/1, 3/1, and 2/1. As shown in Fig. 3 , an increase in spectral shift was observed with decreasing AuNR/CHC ratio for all investigated HSA concentrations. The upper limit in concentration for reliable concentration determination was about 10 5 pM, above this concentration the peak shift plateaued and no significant difference could be detected. The LDL was as low as ~1.50 pM for an AuNR/CHC ratio of 2, which was a 100-fold improvement compared to the LDL for an AuNR/CHC ratio of 4.
Furthermore, at this ratio the peak shift in response to HSA concentration was larger than that observed for dispersed AuNRs in previous work. 24 Unfortunately, further reduction of the AuNR/CHC ratio resulted in poor signal-to-noise that prevented reliable determination of the peak shift (data not shown). Thus the CHC-AuNR nanoprobe with an AuNR/CHC ratio of 2 can be considered an optimized version of the nanoprobe for use with readily available and low cost UV-visible spectroscopy, allowing for detection of a HSA concentration as low as 1.5 pM in SU. This LDL is a 10-fold improvement compared to that previously reported for the non-optimized CHC-AuNR nanoprobe system in DI water [24] , which is quite remarkable flavone-based fluorescent probe, LDL = 1.4 nM [34] ; optical quantum dot-based immunosensor, LDL = 480 pM [35] . A LDL in the attomolar range has recently been reported against IgE proteins for an AuNR-SPR-based sensor [36] . Even if that technology has a lower LDL, it relied on SPR-specific instrumentation, an analysis time in the hours-range and analyses were seemingly conducted in non-complex solutions. In contrast, the CHC-AuNR system holds merit in that it can be used with readily available UV-visible instruments, offers fast analysis time (as further discussed in section 3.3. below) and that the performance was demonstrated in SU.
Although speculative, extrapolation of the AuNR/CHC ratio towards lower values, as given in Fig. 4 , also suggests that a lower LDL may be possible for the CHC-AuNR nanoprobe by utilization of spectroscopic techniques/instruments that enable acquisition of spectra with higher signal-to-noise at lower AuNR/CHC ratios. For example, the extrapolation indicates that a LDL of 100 fM could be achieved for an AuNR/CHC ratio of 1.2. 
Kinetics of HSA adsorption
The spectral shift is a result from HSA adsorption on the AuNR surface. The kinetics of the deposition will determine the time required to reach equilibrium. This will in turn determine the response time of the biosensor system as equilibrium is needed to reliably determine the concentration of the analyte. Therefore, adsorption kinetics of HSA onto the nanoprobe system with an AuNR/CHC ratio of 2 was investigated by observing the peak shift over time for HSA concentrations in the range 150 pM -150 nM.
As seen in Fig. 5 , the spectral shift reached a plateau in less than 900 seconds for all investigated HSA concentrations, with the equilibrium seemingly being established quicker for lower concentrations. Based on the results it was concluded that an incubation time of 15 minutes was enough to ensure that the peak shift was close to equilibrium for relevant concentrations of HSA. Importantly, this time is short enough to allow for practical use of the nanoprobe system. (Fig. 6b) . These results confirm that there was preferential adsorption of HSA onto the AuNRs also in SU.
The attractive interactions have previously been attributed to pH-dependent electrostatic interactions in DI water [24] and the mechanism should be the same in SU. 
Conclusions
The biosensing concept of electrostatic-based, pH-dependent analyte specificity of AuNRs adsorbed on self-assembled CHC nanocarriers was optimized and demonstrated to achieve sensitive detection of HSA in SU. By controlling the ratio between AuNRs and CHC nanocarriers the response and sensitivity (lower detection limit) could be tuned. The results indicated that the lower the AuNR to CHC ratio, the better the response and sensitivity. However, due to limitations from signal-to-noise in the used UV-visible spectroscopic methodology, the lowest ratio that was practically feasible was an estimated 2 AuNRs per CHC nanocarrier, allowing for detection of 1.5 pM HSA in SU, a 100-fold improvement compared with the ratio of 4/1.
Furthermore, this LDL was a 10-fold improvement compared to that previously reported for a non-optimized CHC-AuNR system in the less complex environment of DI water. This pM LDL is also lower than what has been reported in recent literature for several HSA-sensing systems [32] [33] [34] [35] . The results confirm the potential for using this sensitive nanoprobe in complex environments. It is however recognized that further experiments and optimization, using real urine samples from patients, is required to evaluate the potential of the system to indicate disease from urine tests in a clinical setting. In real samples any peak shift-analyte concentration correlations may be confounded by presence of other organic molecules that also adsorb at a given pH and their inter-individual variations. To circumvent this problem we hypothesize that a multivariate approach may be used to screen for diseases by recording the peak shift pH-peak shift fingerprint characteristic for certain conditions, which could provide extremely powerful if successful. Such investigations will, however, require a large number of participants with clinically 15 classified conditions and will thus be a subject of future investigations. While more sensitive techniques are available, the nanoprobe system should hold merit in that it is ligand-free and utilizes readily available UV-visible spectroscopy for analysis.
